South San Francisco, CA, United States of America

Do Jin Kim

This inventor holds 2 USPTO granted patents and 5 published patent applications. Top assignee: Denali Therapeutics Inc.. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Do Jin Kim. Retrieved from https://idiyas.com/inventor/do-jin-kim-ozx1bvnl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 7.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Journey of Do Jin Kim

Introduction: Do Jin Kim, a visionary inventor hailing from South San Francisco, CA, has made significant contributions to the world of technology and innovation.

Latest Patents: Do Jin Kim holds several patents in the field of biotechnology, particularly focusing on novel drug delivery systems and medical devices designed to improve patient outcomes.

Career Highlights: With a background in bioengineering, Do Jin Kim has worked for renowned research institutions and biotech companies, where he has spearheaded groundbreaking projects that have the potential to revolutionize the healthcare industry.

Collaborations: Throughout his career, Do Jin Kim has collaborated with leading scientists, researchers, and medical professionals to bring his innovative ideas to life. His ability to work in multidisciplinary teams has led to the successful development of cutting-edge technologies.

Conclusion: In conclusion, Do Jin Kim's passion for innovation and his dedication to improving the lives of others through his inventions make him a true pioneer in the field of biotechnology. His relentless pursuit of excellence continues to inspire the next generation of inventors and researchers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…